Physician profile
Anna Roysman
NPI 1063503464
$9,153.31
in general payments reported to CMS, 2019-2025
48 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $569 · 2021: $1,491 · 2022: $1,933 · 2023: $1,407 · 2024: $1,637 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,449.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,627.96 | 2019-2025 | Linzess, Viberzi, Creon |
| Nestle Healthcare Nutrition INC. | $1,632.92 | 2020-2023 | |
| Novo Nordisk INC | $1,023.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Aimmune Therapeutics, INC. | $497.59 | 2024-2025 | Zenpep |
| Glaxosmithkline, LLC. | $382.54 | 2019-2024 | Bexsero, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $377.63 | 2019-2025 | Breztri, Tezspire, Farxiga |
| Janssen Pharmaceuticals, INC | $261.22 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.39 | 2019-2022 | |
| Janssen Biotech, INC. | $161.80 | 2022-2023 | Tremfya |
| Alk-Abello, INC | $139.77 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Exact Sciences Corporation | $137.52 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $136.54 | 2019-2024 | Verquvo, Gardasil 9, Vaxelis |
| Biogen, INC. | $120.07 | 2023-2025 | Vumerity, Tysabri |
| Redhill Biopharma INC. | $110.50 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $93.36 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Roysman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.